Two separate surveys show that the Latino and Black community are cautious about getting the coronavirus vaccine.
The coronavirus vaccine is almost here. While most people anticipate getting the coronavirus vaccine as they eagerly await to get back to everyday life, some are considering not getting vaccinated.
Six in ten people say they would definitely or probably get a coronavirus vaccine if it were available today, up 9% points from 51% in September, a Pew Research Center study shows. According to the Associated Press, another survey shows that only about half of Americans will get vaccinated.
While the Black and Latino communities have been disproportionately affected by the coronavirus more than any other group, they are less likely to get the vaccine.
Here’s the breakdown, according to Pew Research:
- 42% of Black Americans say they will get vaccinated.
- 63% of Latinos say they will get vaccinated.
- 61% of white adults say they will get vaccinated.
- 83% of Asian-Americans say they will get vaccinated.
The AP survey shows even less confidence:
- 24% of Black Americans will get vaccinated.
- 34% of Latinos will get vaccinated.
- 53% of white Americans will get vaccinated.
Because of the insufficient sample size, the AP survey could not analyze results among Native Americans or other racial and ethnic groups that make up a smaller portion of the US population.
“If Dr. Fauci says it’s good, I will do it,” Mary Lang, 71, of Fremont, California, told the AP. She added, “Hopefully, if enough of us get the vaccine, we can make this virus go away.”
Experts estimate at least 70% of the US population needs to be vaccinated to achieve herd immunity, the point at which enough people are protected that the virus can be held in check.
“Even if it helps a little bit, I’d take it,” Ralph Martínez, 67, who manages a grocery store in Dallas, told the AP. “I honestly think they wouldn’t put something out there that would hurt us.”
The Pew Research study shows that those with higher family incomes, adjusted for cost of living and household size, are also more likely than those with middle or lower incomes to say they would get the coronavirus vaccine.
Early data suggests the two US frontrunners—one vaccine made by Pfizer and BioNTech, and another by Moderna and the National Institute of Health—offer strong protection. The Food and Drug Administration is poring over study results to be sure the shots are safe before deciding in the coming days whether to allow mass vaccinations, as Britain began doing with Pfizer’s shots on Tuesday.
The Associated Press contributed to this story.